Home / Recalls / Medical Devices
Abbott Molecular, Inc. recalls Alinity m HBV Application Specification File (US and CE)
Recalled April 13, 2022 · FDA recall Z-0883-2022 · Abbott Molecular
Hazard
There is a potential for misquantitation high results of negative samples. · FDA Class II
Sold at
US consignees - AZ, CA, IL, IN, MA, MI, MO, NH, NJ, NY, OH, SD, TX, and VA OUS consignees - Australia, Austria, Belgium, Brazil, Canada, Columbia, Czech Republic, El Salvador, Estonia, France, Germany, Israel, Italy, Japan, Latvia, Malaysia, Netherlands, New Zealand, Norway, Pakistan, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sweden, Switzerland, Taiwan, Thailand, United Kingdom, and Vietnam
Description
There is a potential for misquantitation high results of negative samples.
Product
Alinity m HBV Application Specification File (US and CE)
Manufacturer(s)
Abbott Molecular, Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →